Guella I et al. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy. Am J Hum Genet. 2017 3;101(2):300-310. PMID: 28777935.
Kanani F et al. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy. Am J Med Genet A. 2020;182(4):713-720. PMID: 31926053.
Komoike Y et al. Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly. Genesis. 2010;48(4):233-43. PMID: 20146355.
Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 2009;19(1):16-23. PMID: 19027299.
Nicotera AG et al. Epileptic Phenotype and Cannabidiol Efficacy in a Williams-Beuren Syndrome Patient With Atypical Deletion: A Case Report. Front Neurol. 2021 8;12:659543. PMID: 34168609.
Stern T et al. Epilepsy and electroencephalogram evolution in YWHAG gene mutation: A new phenotype and review of the literature. Am J Med Genet A. 2021;185(3):901-908. PMID: 33393734.
Ye XG et al. YWHAG Mutations Cause Childhood Myoclonic Epilepsy and Febrile Seizures: Molecular Sub-regional Effect and Mechanism. Front Genet. 2021 9;12:632466. PMID: 33767733.
Yi Z et al. A heterozygous missense variant in the YWHAG gene causing developmental and epileptic encephalopathy 56 in a Chinese family. BMC Med Genomics. 2022 15;15(1):216. PMID: 36243722.